GenScript

GenScript is a New Jersey-based biotech company that discovers, develops and commercializes industrial synthetic products and cell therapeutic solutions. Read more

CEO Avatar

CEO

Zhenyu Liu

CEO Approval Rating

84/100

Founded:

2002

Status:

PublicIndependent CompanyHong Kong Stock Exchange1548

GENSCRIPT TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Clinipace is seen as one of GenScript's biggest rivals. Clinipace was founded in 2003 in Morrisville, North Carolina. Clinipace operates in the Medical Research & Laboratories industry. Clinipace generates $268.8M less revenue than GenScript.

Bioclinica is one of GenScript's top competitors. Bioclinica was founded in 1987, and its headquarters is in Princeton, New Jersey. Bioclinica operates in the Medical Research & Laboratories industry. Bioclinica has 1,401 fewer employees than GenScript.

QPS is one of GenScript's top rivals. QPS was founded in 1995, and is headquartered in Newark, Delaware. QPS is in the Medical Research & Laboratories field. QPS generates $250.8M less revenue vs. GenScript.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Lifetein a competitor of GenScript?

GenScript Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$390.8M

GenScript's revenue is the ranked 1st among it's top 10 competitors. The top 10 competitors average 82.4M. Over the last three quarters, GenScript's revenue has decreased by 0%. Specifically, in Q4 2020's revenue was $390.8M; in Q3 2020, it was $390.8M; in Q2 2020, it was $390.8M.

GenScript Acquisitions

No recent acquisitions found related to GenScript

GenScript Funding History

Since GenScript was founded in 2002, it has participated in 3 rounds of funding. In total GenScript has raised $1.1B. GenScript's last funding round was on May 2021 for a total of $1.0B

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Post-IPO Equity
May 2021
$1B

Hillhouse Capital

IPO
Dec 2015
$67M
-
Venture Round
Jun 2009
$15M

Since GenScript was founded in 2002, it has participated in 3 rounds of funding. In total GenScript has raised $1.1B. GenScript's last funding round was on May 2021 for a total of $1.0B

GenScript Investments

No recent investments found related to GenScript

GenScript News

May 12, 2021Biospectrum Asia

ERS Genomics and GenScript sign CRISPR/Cas9 license agreement

License agreement to enhance GenScript's CRISPR offering for gene and cell therapy research... See more »
April 30, 2021MarketScreener

VOLUNTARY ANNOUNCEMENT-RESEARCH AND DEVELOPMENT UPDATE

(marketscreener.com) Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Lim... See more »
April 29, 2021Contract Pharma

GenScript Launches Research Lentiviral Vector Packaging Service

Enables scientists to package their genetic material of choice to ensure consistent production of fun... See more »
April 21, 2021Biospectrum Asia

Singapore lays focus on anti-fibrosis therapeutic antibody programme

GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre... See more »
April 15, 2021NS Medical Devices

GenScript Biotech BV and IES Diagnostics forge distribution agreement for SARS-CoV-2 neutralising antibody kit

The post GenScript Biotech BV and IES Diagnostics forge distribution agreement for SARS-CoV-2 neutral... See more »
April 12, 2021MarketScreener

, Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate to provide cPass SARS-CoV-2 Neutralizing Antibody Testing Service in Singapore

(marketscreener.com) Company » Company News » Press Releases » GenScript, Parkway Laboratories and Di... See more »
March 29, 2021FinanzNachrichten

GenScript Biotech Reports Full Year 2020 Financial Results

NANJING, China, Mar. 29, 2021 /PRNewswire/ -- GenScript Biotech Corporation (HKEX: 1548.HK) today hel... See more »

GenScript Press Releases

October 19, 2020GlobeNewswire

Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay for Treatment of COVID-19

NEW YORK and SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BT... See more »
September 10, 2020NewsVoir

GenScript Biotech Corporation Enters Strategic Distributor Partnership with Premas Life Sciences to Distribute cPassTM SARS CoV-2 Neutralization Antibody Detection Kit in India

GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology comp... See more »
August 15, 2020PRcom

Cayman and GenScript Partner to Offer Neoantigen Profiling and Synthesis Expertise

Cayman and GenScript have come together to create a complete package of neoantigen discovery services... See more »
July 24, 2020StreetInsider

GenScript Highlights Tailor-Made Mutant Libraries For Therapeutic Applications at Protein Engineering Congress

PISCATAWAY, N.J., July 24, 2020 /PRNewswire/ --Â GenScript, the world's leading...... See more »
April 23, 2020PRWeb

Mount Sinai Researchers Collaborate with GenScript to Develop a COVID-19 Antibody to Treat Sick Patients

The highly targeted antibody may block the coronaviruses' ability to enter human lung cells(PRWeb Apr... See more »
April 1, 2020PR Newswire

GenScript Launches Neoantigen Specific Peptide Synthesis Service for Precision Immuno-oncology Therapeutic Development

/PRNewswire/ -- GenScript, a world leading biotechnology company, today announced the commercial laun... See more »

GenScript Videos

Social Media

GenScript Headquarters

860 Centennial Avenue

Piscataway, New Jersey08854

1-732-885-9188

Driving Directions »

Trending Companies

GenScript Summary

ABOUT

Overview

GenScript is a New Jersey-based biotech company that discovers, develops and commercializes industrial synthetic products and cell therapeutic solutions. GenScript was founded in 2002. GenScript's headquarters is located in Piscataway, New Jersey, USA...

CEO

GenScript's CEO, Zhenyu Liu, currently has an approval rating of 84%. GenScript's primary competitors are Clinipace, Bioclinica & QPS.

Frequently Asked Questions about GenScript

  1. When was GenScript founded?

    GenScript was founded in 2002
  2. Who is GenScript's CEO?

    GenScript's CEO is Zhenyu Liu
  3. How much revenue does GenScript generate?

    GenScript generates $390.8M in revenue
  4. How much funding does GenScript have?

    GenScript has historically raised $1.1B in funding
  1. Where is GenScript's headquarters?

    GenScript's headquarters is in Piscataway New Jersey, USA
  2. How many employees does GenScript have?

    GenScript has 4,601 employees
  3. What sector does GenScript operate in?

    GenScript is in Biotechnology
  4. Who are GenScript's competitors?

    GenScript's top competitors are Clinipace, Bioclinica, QPS